Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oxygen sensing in cancer.

Christopher W Pugh1

  • 1Henry Wellcome Building of Genomic Medicine, University of Oxford, Headington, UK. cpugh@well.ox.ac.uk

Annals of Medicine
|October 24, 2003
PubMed
Summary

Hypoxia-inducible factor-1 (HIF) pathway activation is common in tumors, influencing gene expression and tumor progression. Understanding HIF regulation is key to targeting cancer

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIFα isoform specific activities drive cell-type specificity of VHL-associated oncogenesis.

Nature communications·2025
Same author

Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8<sup>+</sup> T cells.

Nature communications·2024
Same author

Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8<sup>+</sup> T cells.

Nature communications·2024
Same author

Lung Ultrasound Reproducibly Outperforms Computed Tomography in the Detection of Extravascular Lung Water in Patients Undergoing Haemodialysis.

Diagnostics (Basel, Switzerland)·2024
Same author

Oncogenic Cell Tagging and Single-Cell Transcriptomics Reveal Cell Type-Specific and Time-Resolved Responses to Vhl Inactivation in the Kidney.

Cancer research·2024
Same author

Author Correction: Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation.

Nature immunology·2022

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Hypoxia, a low-oxygen state, is common in tumors and impacts cancer prognosis.
  • The hypoxia-inducible factor-1 (HIF) pathway is frequently upregulated in cancer, affecting tumor-promoting and tumor-suppressing genes.
  • HIF levels can increase due to the tumor microenvironment or genetic mutations, such as those in the von Hippel-Lindau (VHL) protein.

Purpose of the Study:

  • To explore the regulatory mechanisms of HIF.
  • To understand the role of HIF in balancing cellular processes like energy production and iron metabolism.
  • To investigate how HIF pathway co-selection contributes to tumor characteristics like the Warburg effect and angiogenesis.

Main Methods:

  • Review of current literature on HIF regulation and function in cancer.
  • Analysis of the interplay between HIF, amino acid hydroxylases, and cellular metabolism.
  • Examination of evolutionary selection pressures on HIF-driven tumor traits.

Main Results:

  • Elucidation of HIF regulation by amino acid hydroxylases, linking it to energy, iron, and oxygen balance.
  • Hypothesis that co-selection of HIF-regulated genes explains the glycolytic phenotype (Warburg effect) in tumors.
  • Proposed that HIF-driven tumor angiogenesis, while beneficial to the tumor mass, is not directly selected at the clonal level.

Conclusions:

  • The HIF pathway is a critical regulator in the hypoxic tumor microenvironment.
  • Understanding HIF regulation offers potential therapeutic targets for cancer treatment.
  • HIF-mediated co-selection provides a framework for understanding the evolution of complex tumor phenotypes like angiogenesis and altered metabolism.

Related Experiment Videos